Written Description

• 3/17/2025

  Federal Circuit Clarifies Written Description and Preamble Limitations in In re Xencor, Inc. Decision

• 1/11/2025

  Federal Circuit Reverses Invalidity Finding for Novartis’ Entresto Patent